Falsified antimalarial medication in Africa
The 2011 WHO report, published last December, highlighted the fact that between 2000 and 2010, recorded cases of malaria dropped by over 50% in 43 of the 99 countries affected by the transmission. The study led by Dr. Newton, of the Welcome Trust Foundation and Oxford University, underlined the circulation of substandard antimalarial drugs in Africa.
Published in the Malaria Journal, it denounced these dangerous drugs that are produced by criminal networks or are poorly dosed due to factory error.
It goes on to state that both these types of non-conformities are not only harmful to patients, but they also lead to drug resistance in malaria parasites.
Researchers collected data in 11 African countries between 2002 and 2010 before demonstrating that substandard ingredients or dosages threaten millions of people.
This is why they are calling on national regulatory authorities in Africa to invest in the legislation on drug quality.